171 related articles for article (PubMed ID: 38576720)
21. Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers.
Fang D; Wang R; Yu X; Tian Y
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190296
[TBL] [Abstract][Full Text] [Related]
22. Toward the elucidation of the mechanism for passive membrane permeability of cyclic peptides.
Riniker S
Future Med Chem; 2019 Apr; 11(7):637-639. PubMed ID: 30920310
[No Abstract] [Full Text] [Related]
23. Conformationally constrained macrocycles that mimic tripeptide beta-strands in water and aprotic solvents.
Reid RC; Kelso MJ; Scanlon MJ; Fairlie DP
J Am Chem Soc; 2002 May; 124(20):5673-83. PubMed ID: 12010040
[TBL] [Abstract][Full Text] [Related]
24. Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.
Witek J; Wang S; Schroeder B; Lingwood R; Dounas A; Roth HJ; Fouché M; Blatter M; Lemke O; Keller B; Riniker S
J Chem Inf Model; 2019 Jan; 59(1):294-308. PubMed ID: 30457855
[TBL] [Abstract][Full Text] [Related]
25. Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry.
Furukawa A; Townsend CE; Schwochert J; Pye CR; Bednarek MA; Lokey RS
J Med Chem; 2016 Oct; 59(20):9503-9512. PubMed ID: 27690434
[TBL] [Abstract][Full Text] [Related]
26. Anthranilic acid-containing cyclic tetrapeptides: at the crossroads of conformational rigidity and synthetic accessibility.
Xin D; Burgess K
Org Biomol Chem; 2016 Jun; 14(22):5049-58. PubMed ID: 27173439
[TBL] [Abstract][Full Text] [Related]
27. Impact of Cyclization and Methylation on Peptide Penetration through Droplet Interface Bilayers.
Faugeras V; Duclos O; Bazile D; Thiam AR
Langmuir; 2022 May; 38(18):5682-5691. PubMed ID: 35452243
[TBL] [Abstract][Full Text] [Related]
28. Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif.
Wen J; Liao H; Stachowski K; Hempfling JP; Qian Z; Yuan C; Foster MP; Pei D
Bioorg Med Chem; 2020 Oct; 28(20):115711. PubMed ID: 33069067
[TBL] [Abstract][Full Text] [Related]
29. The effect of beta-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers.
Knipp GT; Vander Velde DG; Siahaan TJ; Borchardt RT
Pharm Res; 1997 Oct; 14(10):1332-40. PubMed ID: 9358544
[TBL] [Abstract][Full Text] [Related]
30. Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay.
Foley CA; Potjewyd F; Lamb KN; James LI; Frye SV
ACS Chem Biol; 2020 Jan; 15(1):290-295. PubMed ID: 31846298
[TBL] [Abstract][Full Text] [Related]
31. Emerging Methods and Design Principles for Cell-Penetrant Peptides.
Peraro L; Kritzer JA
Angew Chem Int Ed Engl; 2018 Sep; 57(37):11868-11881. PubMed ID: 29740917
[TBL] [Abstract][Full Text] [Related]
32. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.
Rezai T; Bock JE; Zhou MV; Kalyanaraman C; Lokey RS; Jacobson MP
J Am Chem Soc; 2006 Nov; 128(43):14073-80. PubMed ID: 17061890
[TBL] [Abstract][Full Text] [Related]
33. A novel amphipathic cell-penetrating peptide based on the N-terminal glycosaminoglycan binding region of human apolipoprotein E.
Ohgita T; Takechi-Haraya Y; Nadai R; Kotani M; Tamura Y; Nishikiori K; Nishitsuji K; Uchimura K; Hasegawa K; Sakai-Kato K; Akaji K; Saito H
Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):541-549. PubMed ID: 30562499
[TBL] [Abstract][Full Text] [Related]
34. Double-helical cyclic peptides: design, synthesis, and crystal structure of figure-eight mirror-image conformers of adamantane-constrained cystine-containing cyclic peptide cyclo (Adm-Cyst)(3).
Ranganathan D; Haridas V; Nagaraj R; Karle IL
J Org Chem; 2000 Jul; 65(14):4415-22. PubMed ID: 10891146
[TBL] [Abstract][Full Text] [Related]
35. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
36. Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products.
Ahlbach CL; Lexa KW; Bockus AT; Chen V; Crews P; Jacobson MP; Lokey RS
Future Med Chem; 2015; 7(16):2121-30. PubMed ID: 26067057
[TBL] [Abstract][Full Text] [Related]
37. Cell Permeability of Isomeric Macrocycles: Predictions and NMR Studies.
Begnini F; Poongavanam V; Atilaw Y; Erdelyi M; Schiesser S; Kihlberg J
ACS Med Chem Lett; 2021 Jun; 12(6):983-990. PubMed ID: 34136079
[TBL] [Abstract][Full Text] [Related]
38. Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides.
Wang S; König G; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2021 Sep; 64(17):12761-12773. PubMed ID: 34406766
[TBL] [Abstract][Full Text] [Related]
39. Biological Membrane-Penetrating Peptides: Computational Prediction and Applications.
de Oliveira ECL; da Costa KS; Taube PS; Lima AH; Junior CSS
Front Cell Infect Microbiol; 2022; 12():838259. PubMed ID: 35402305
[TBL] [Abstract][Full Text] [Related]
40. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
